Literature DB >> 34109729

Unraveling the heterogeneity in Alzheimer's disease progression across multiple cohorts and the implications for data-driven disease modeling.

Colin Birkenbihl1,2, Yasamin Salimi1,2, Holger Fröhlich1,2.   

Abstract

INTRODUCTION: Given study-specific inclusion and exclusion criteria, Alzheimer's disease (AD) cohort studies effectively sample from different statistical distributions. This heterogeneity can propagate into cohort-specific signals and subsequently bias data-driven investigations of disease progression patterns.
METHODS: We built multi-state models for six independent AD cohort datasets to statistically compare disease progression patterns across them. Additionally, we propose a novel method for clustering cohorts with regard to their progression signals.
RESULTS: We identified significant differences in progression patterns across cohorts. Models trained on cohort data learned cohort-specific effects that bias their estimations. We demonstrated how six cohorts relate to each other regarding their disease progression. DISCUSSION: Heterogeneity in cohort datasets impedes the reproducibility of data-driven results and validation of progression models generated on single cohorts. To ensure robust scientific insights, it is advisable to externally validate results in independent cohort datasets. The proposed clustering assesses the comparability of cohorts in an unbiased, data-driven manner.
© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's disease; cohort study; data mining; data-driven; disease modeling; machine learning; sampling bias; statistical learning; translational research

Mesh:

Year:  2021        PMID: 34109729     DOI: 10.1002/alz.12387

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  3 in total

1.  ADataViewer: exploring semantically harmonized Alzheimer's disease cohort datasets.

Authors:  Yasamin Salimi; Daniel Domingo-Fernández; Carlos Bobis-Álvarez; Martin Hofmann-Apitius; Colin Birkenbihl
Journal:  Alzheimers Res Ther       Date:  2022-05-21       Impact factor: 8.823

2.  Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer's disease.

Authors:  Neil P Oxtoby; Colin Birkenbihl; Sepehr Golriz Khatami; Yasamin Salimi; Martin Hofmann-Apitius
Journal:  Alzheimers Res Ther       Date:  2022-04-20       Impact factor: 8.823

3.  Generation of realistic synthetic data using Multimodal Neural Ordinary Differential Equations.

Authors:  Philipp Wendland; Colin Birkenbihl; Marc Gomez-Freixa; Meemansa Sood; Maik Kschischo; Holger Fröhlich
Journal:  NPJ Digit Med       Date:  2022-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.